CANTEL MEDICAL CORP's ticker is CMD and the CUSIP is 138098108. A total of 275 filers reported holding CANTEL MEDICAL CORP in Q1 2018. The put-call ratio across all filers is 1.52 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $207,000 | +20.3% | 2,930 | +28.1% | 0.00% | 0.0% |
Q3 2019 | $172,000 | +3.6% | 2,287 | +11.2% | 0.00% | 0.0% |
Q2 2019 | $166,000 | +8.5% | 2,056 | -10.0% | 0.00% | 0.0% |
Q1 2019 | $153,000 | -26.8% | 2,284 | -18.5% | 0.00% | -50.0% |
Q4 2018 | $209,000 | -17.1% | 2,802 | +2.4% | 0.00% | -33.3% |
Q3 2018 | $252,000 | +39.2% | 2,735 | +48.8% | 0.00% | +50.0% |
Q2 2018 | $181,000 | -15.4% | 1,838 | -4.4% | 0.00% | -33.3% |
Q1 2018 | $214,000 | -17.4% | 1,923 | -23.6% | 0.00% | 0.0% |
Q4 2017 | $259,000 | +1.6% | 2,517 | -6.9% | 0.00% | -25.0% |
Q3 2017 | $255,000 | +2.4% | 2,703 | -15.1% | 0.00% | 0.0% |
Q2 2017 | $249,000 | -3.9% | 3,182 | -1.0% | 0.00% | -20.0% |
Q1 2017 | $259,000 | -11.3% | 3,214 | -13.3% | 0.01% | -28.6% |
Q4 2016 | $292,000 | -13.1% | 3,706 | -13.7% | 0.01% | -12.5% |
Q3 2016 | $336,000 | +24.4% | 4,296 | +8.6% | 0.01% | +14.3% |
Q2 2016 | $270,000 | – | 3,954 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DIKER MANAGEMENT LLC | 1,084,317 | $85,509,000 | 43.23% |
Leonard Green & Partners, L.P. | 2,100,000 | $165,606,000 | 2.29% |
Champlain Investment Partners, LLC | 3,952,620 | $311,704,000 | 1.79% |
Brown Capital Management | 2,454,770 | $193,583,000 | 1.34% |
Aurora Investment Counsel | 19,502 | $1,538,000 | 1.24% |
Conestoga Capital Advisors, LLC | 797,481 | $62,889,000 | 1.00% |
EMERALD ADVISERS, LLC | 292,554 | $23,071,000 | 0.77% |
FRED ALGER MANAGEMENT, LLC | 3,470,340 | $273,671,000 | 0.71% |
GENEVA CAPITAL MANAGEMENT LLC | 510,171 | $40,232,000 | 0.68% |
WASHINGTON CAPITAL MANAGEMENT, INC | 7,650 | $603,000 | 0.58% |